Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Petlife Pharmaceuticals Inc (EM) PTLF

Healthcare Biotechnology Drug Manufacturers - Specialty & Generic
Petlife Pharmaceuticals, Inc. engages in the research, development, sale, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases, such as arthritis in the United States. The company’s principal product is Vitalzul that inhibits blood vessels formation in solid tumors. It is also developing Vitalzul as a prescription strength oral pharmaceutical, as well as a... see more

Current News (EXPM:PTLF)

Byzen Digital Changes Name and Ticker Symbol to Clean Vision Corporation and CLNV; New Name Reflects Ongoing Pivot to Green, Sustainable Technologies

ACCESS Newswire April 22, 2021

PetLife Pharmaceuticals Announces Haiti Veterinary Initiative

ACCESS Newswire October 19, 2017

PetLife Pharmaceuticals Gets 'On the Road Again!' With 2 Scheduled Road Shows in California

ACCESS Newswire July 31, 2017

PetLife Pharmaceuticals' CEO, Dr. Ralph Salvagno, Issues Letter to Shareholders

ACCESS Newswire July 20, 2017

PetLife Announces its All-natural 'Cancer Cocktail' With Applicability to Pet and Human Markets

PR Newswire June 14, 2017

PetLife Completes Its TV Commercial for Newly Acquired Dr. Geoff's by PetLife, Preparing for Regional Launch

ACCESS Newswire June 6, 2017

PetLife Pharmaceuticals Launches New Website

ACCESS Newswire June 1, 2017

PetLife Files for Patent for the Treatment of Cancer for Pets

ACCESS Newswire May 30, 2017

PetLife Explores New Scorpion Venom-Based Therapies for Growing Product Line

ACCESS Newswire May 26, 2017
View More News ››

Opinion & Analysis (EXPM:PTLF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:PTLF)

RE:Anybody heard anything about this stock?

I have some of this stock. It seems to be dormant and just a shell for now. Here are some cliff notes from a filing that I pulled off of...
AZSooner - June 6, 2018

Anybody heard anything about this stock?

Looking for any info on this stock...  there doesn't seem to be much out there.
gmoney80 - September 18, 2017
View more Bullboard ››

Avrupa Minerals Ltd.

Avrupa Minerals Ltd.

Avrupa Minerals Ltd., a junior exploration and development company, engages in the acquisition and exploration of mineral ...
View More »

Podcasts